BRPC	Borderline resectable pancreatic cancer
CA 19-9	Carbohydrate antigen 19-9
CAP	College of American Pathologists
DGE	Delayed gastric emptying
ECOG	Eastern Cooperative Oncology Group
EORTC QLQ C-30	European Organization for Research and Treatment Center Quality of Life Core Questionnaire
IQR	Interquartile ranges
LAPC	Locally advanced pancreatic cancer
mFOLFIRINOX	modified 5-fluorouracil with leucovorin, irinotecan, and oxaliplatin
NCCN	National Comprehensive Cancer Network
OS	Overall survival
PPH	Post-pancreatectomy hemorrhage
POPF	Postoperative pancreatic fistula
QoL	Quality of life
RECIST	Response Evaluation Criteria in Solid Tumors
RFS	Recurrence-free survival
SMA	Superior mesenteric artery
SMV	Superior mesenteric vein